BGICC25 Updates: Dr. Joseph Gligorov on Breast Cancer Advances
The 17th BGICC (Breast Gynecological and Immunooncology International Cancer Conference) was held on 23rd-24th January 2025 at the Hilton Heliopolis Hotel in Cairo, Egypt. This conference, recognized as the largest and most prestigious cancer event in Africa and the Middle East, served as a major platform for discussing the latest updates and trends in breast and gynecological cancers.
Under the slogan “Illumination and Creation,” it also highlighted advancements in genetics and immuno-oncology, covering all oncology aspects from diagnosis to future innovations. The event featured a range of scientific and educational symposia, workshops, debates, and recommendation sessions, with collaborations from world-renowned scientists and esteemed societies.
Dr. Joseph Gligorov, a professor at Sorbonne University, joins OncoDaily to share insights on advancements in metastatic breast cancer at BGICC 2025. He highlights the potential of oral SERDs, supported by data from the EMERALD and EMBER-3 trials, to revolutionize treatment for ESR1-mutated tumors. Tune in to explore their efficacy, safety, and future impact on care standards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023